Your browser doesn't support javascript.
loading
Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
Jarzabek, Monika A; Proctor, William R; Vogt, Jennifer; Desai, Rupal; Dicker, Patrick; Cain, Gary; Raja, Rajiv; Brodbeck, Jens; Stevens, Dale; van der Stok, Eric P; Martens, John W M; Verhoef, Cornelis; Hegde, Priti S; Byrne, Annette T; Tarrant, Jacqueline M.
Afiliación
  • Jarzabek MA; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Proctor WR; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Vogt J; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Desai R; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.
  • Dicker P; Department of Epidemiology and Public Health Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Cain G; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Raja R; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.
  • Brodbeck J; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • Stevens D; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
  • van der Stok EP; Department of Surgical Oncology, Erasmus MC, Rotterdam, Netherlands.
  • Martens JWM; Department of Medical Oncology, Erasmus MC, Rotterdam, Netherlands.
  • Verhoef C; Department of Surgical Oncology, Erasmus MC, Rotterdam, Netherlands.
  • Hegde PS; Department of Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America.
  • Byrne AT; Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Tarrant JM; Department of Safety Assessment, Genentech Inc., South San Francisco, California, United States of America.
PLoS One ; 13(6): e0198099, 2018.
Article en En | MEDLINE | ID: mdl-29879147
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Enfermedad Hepática Inducida por Sustancias y Drogas / Transcriptoma / Oxaliplatino / Hígado Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Enfermedad Hepática Inducida por Sustancias y Drogas / Transcriptoma / Oxaliplatino / Hígado Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Irlanda